Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.42 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.42 |
| ▸ | HTR3B | O95264 | 1/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.42 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | PNMT | P11086 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11689257 | 0.89 | MAPT (0.58) | MAPTALDH1A1HTTRAB9ASMN1; SMN2 | |
| SCHEMBL30197830 | 0.82 | MAPT (0.69) | MAPTALDH1A1HTTRAB9ASMN1; SMN2 | |
| SCHEMBL2767092 | 0.82 | MAPT (0.69) | MAPTALDH1A1HTTRAB9ASMN1; SMN2 | |
| SCHEMBL11446856 | 0.80 | MAPT (0.52) | MAPTALDH1A1HTTRAB9ASMN1; SMN2 | |
| SCHEMBL11133767 | 0.79 | MAPT (0.65) | MAPTALDH1A1TAAR1HTR3EHTR3B | |
| SCHEMBL11670488 | 0.78 | MAPT (0.46) | MAPTALDH1A1HTTRAB9ASMN1; SMN2 | |
| SCHEMBL10993752 | 0.78 | RAB9A (0.44) | MAPTALDH1A1HTTRAB9ASMN1; SMN2 | |
| SCHEMBL1679639 | 0.78 | MAPT (0.44) | MAPTALDH1A1SMN1; SMN2EGFRERBB2 | |
| SCHEMBL11414694 | 0.77 | MAPT (0.62) | MAPTALDH1A1HTTRAB9ASMN1; SMN2 | |
| SCHEMBL9762962 | 0.77 | MAPT (0.62) | MAPTALDH1A1TAAR1HTR3EHTR3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210052577-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2021-02-25 | — | — | US | disclosed |
| US-20200253965-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2020-08-13 | — | — | US | disclosed |
| US-20200038396-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2020-02-06 | — | — | US | disclosed |
| US-20190231774-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2019-08-01 | — | — | US | disclosed |
| US-20180161323-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2018-06-14 | — | — | US | disclosed |
| US-20180161323-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2018-06-14 | — | — | US | disclosed |
| US-20170333425-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2017-11-23 | — | — | US | disclosed |
| US-20170333425-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2017-11-23 | — | — | US | disclosed |
| US-20170128442-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2017-05-11 | — | — | US | disclosed |
| US-20170128442-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2017-05-11 | — | — | US | disclosed |
| US-20130012520-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.P.A. (IT) | 2013-01-10 | — | — | US | disclosed |
| US-8314236-B2 | Trazodone and trazodone hydrochloride in purified form | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2012-11-20 | — | — | US | disclosed |
| US-8314236-B2 | Trazodone and trazodone hydrochloride in purified form | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2012-11-20 | — | — | US | disclosed |
| US-20120142699-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.P.A. (IT) | 2012-06-07 | — | — | US | disclosed |
| US-20120142699-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.P.A. (IT) | 2012-06-07 | — | — | US | disclosed |
| US-8133893-B2 | Trazodone and trazodone hydrochloride in purified form | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2012-03-13 | — | — | US | disclosed |
| US-8133893-B2 | Trazodone and trazodone hydrochloride in purified form | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2012-03-13 | — | — | US | disclosed |
| US-20100056539-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUM. ANG. FRANC. A.C.R.A.F.S.P.A. (IT) | 2010-03-04 | — | — | US | disclosed |
| US-20100056539-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUM. ANG. FRANC. A.C.R.A.F.S.P.A. (IT) | 2010-03-04 | — | — | US | disclosed |
| WO-2009019133-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2009-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056539-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, OPRM1, OPRK1 | MAPT 679/4885ALDH1A1 553/4885HTT 141/4885 |
| US-20210052577-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, OPRK1, OPRM1 | MAPT 645/4885ALDH1A1 521/4885HTT 105/4885 |
| US-20170333425-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | MAPT 701/4885ALDH1A1 675/4885HTT 122/4885 |
| US-20130012520-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | MAPT 701/4885ALDH1A1 675/4885HTT 122/4885 |
| US-20170128442-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | MAPT 701/4885ALDH1A1 675/4885HTT 122/4885 |
| US-20190231774-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | MAPT 701/4885ALDH1A1 675/4885HTT 122/4885 |
| US-20120142699-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | MAPT 701/4885ALDH1A1 675/4885HTT 122/4885 |
| US-20200253965-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | MAPT 701/4885ALDH1A1 675/4885HTT 122/4885 |
| US-20200038396-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | MAPT 687/4885ALDH1A1 690/4885HTT 117/4885 |
| US-20180161323-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | MAPT 701/4885ALDH1A1 675/4885HTT 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.